Your browser doesn't support javascript.
loading
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.
Lombardi, Andrea; Viero, Giulia; Villa, Simone; Biscarini, Simona; Palomba, Emanuele; Azzarà, Cecilia; Iannotti, Nathalie; Mariani, Bianca; Genovese, Camilla; Tomasello, Mara; Tonizzo, Anna; Fava, Marco; Valzano, Antonia Grazia; Morlacchi, Letizia Corinna; Donato, Maria Francesca; Castellano, Giuseppe; Cassin, Ramona; Carrabba, Maria; Muscatello, Antonio; Gori, Andrea; Bandera, Alessandra.
Afiliação
  • Lombardi A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Viero G; Centre for Multidisciplinary Research in Health Science (MACH), University of Milano, 20122 Milan, Italy.
  • Villa S; Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
  • Biscarini S; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Palomba E; Centre for Multidisciplinary Research in Health Science (MACH), University of Milano, 20122 Milan, Italy.
  • Azzarà C; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Iannotti N; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Mariani B; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Genovese C; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Tomasello M; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Tonizzo A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Fava M; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Valzano AG; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Morlacchi LC; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Donato MF; Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Castellano G; Respiratory Unit and Cystic Fibrosis Adult Center, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Cassin R; A.M. & A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Carrabba M; Department of Nephrology, Dialysis, and Renal Transplantation, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Muscatello A; Hematology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Gori A; Department of Internal Medicine, Adult Primary Immunodeficiencies Centre, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Bandera A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Biomedicines ; 11(6)2023 May 26.
Article em En | MEDLINE | ID: mdl-37371635

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article